These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26955964)

  • 1. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
    Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
    Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy.
    Ungureanu BS; Teodorescu CM; Săftoiu A
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):375-83. PubMed ID: 27689203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotheranostics: Their role in hepatocellular carcinoma.
    Malla RR; Kumari S; Kgk D; Momin S; Nagaraju GP
    Crit Rev Oncol Hematol; 2020 Jul; 151():102968. PubMed ID: 32416345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in hepatocellular carcinoma-targeted nanoparticles.
    Liu X; Bai Y; Zhou B; Yao W; Song S; Liu J; Zheng C
    Biomed Mater; 2024 May; 19(4):. PubMed ID: 38697209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.
    Mohamed NK; Hamad MA; Hafez MZ; Wooley KL; Elsabahy M
    Int J Cancer; 2017 Apr; 140(7):1475-1484. PubMed ID: 27861850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-based drug delivery systems in hepatocellular carcinoma.
    Abtahi MS; Fotouhi A; Rezaei N; Akalin H; Ozkul Y; Hossein-Khannazer N; Vosough M
    J Drug Target; 2024 Nov; 32(9):977-995. PubMed ID: 38847573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: Advances in diagnostic imaging.
    Sun H; Song T
    Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
    Ichida T; Van Thiel DH; Hassanein T
    Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in Nanotechnology-Based Drug Delivery Systems in the Treatment of Hepatocellular Carcinoma].
    Yang SL; Xiang Y; Yang YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Jun; 46(3):384-392. PubMed ID: 38953262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
    Li WX; Li Q; Lin Y; Huang YX; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
    Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
    Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of nanomaterial-based treatment for hepatocellular carcinoma.
    Baig B; Halim SA; Farrukh A; Greish Y; Amin A
    Biomed Pharmacother; 2019 Aug; 116():108852. PubMed ID: 30999152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
    Ding B; Li T; Zhang J; Zhao L; Zhai G
    Curr Gene Ther; 2012 Apr; 12(2):92-102. PubMed ID: 22348553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
    Lu J; Wang J; Ling D
    Small; 2018 Feb; 14(5):. PubMed ID: 29251419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review.
    Taymouri S; Taheri A
    Curr Drug Deliv; 2016; 13(5):662-72. PubMed ID: 26343151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
    Wang Z; Zhang G; Wu J; Jia M
    Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.